Both in Biotechnology

Kalaris Therapeutics vs Eloxx Pharmaceuticals

Over the past year KLRS returned −37.9% and ELOX returned −20.0%; their daily moves had a correlation of 0.34.

KLRS −37.9% ELOX −20.0%Growth of $1, one year, split-adjusted
MetricKLRSELOX
Price$2.10$12.60
Market cap$50.0M$50.9M
Today+2.44%−2.48%
1 month−21.1%−16.7%
6 months−58.5%—
Year to date−75.1%—
1 year−57.9%—
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)——
Price / sales——
Net cash$93.5M$62.0M
Dividend yield——
Volatility (60d)56.4%—
Short % of float5.4%1.3%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).